A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/44 (2006.01) A61K 31/415 (2006.01) A61K 31/445 (2006.01) A61K 31/495 (2006.01) A61K 31/505 (2006.01) A61K 31/535 (2006.01) C07D 235/06 (2006.01) C07D 235/10 (2006.01) C07D 235/12 (2006.01) C07D 235/14 (2006.01) C07D 235/16 (2006.01) C07D 235/18 (2006.01) C07D 235/22 (2006.01) C07D 235/24 (2006.01) C07D 235/30 (2006.01) C07D 239/34 (2006.01) C07D 401/04 (2006.01) C07D 401/10 (2006.01) C07D 401/12 (2006.01) C07D 401/14 (2006.01) C07D 403/04 (2006.01) C07D 403/10 (2006.01) C07D 403/12 (2006.01) C07D 40
Patent
CA 2341409
The present invention relates to compounds which inhibit tyrosine kinase enzymes, compositions which contain tyrosine kinase inhibiting compounds and methods of using tyrosine kinase inhibitors to treat tyrosine kinase-dependent diseases/conditions such as angiogenesis, cancer, atherosclerosis, diabetic retinopathy or autoimmune diseases, in mammals.
La présente invention se rapporte à des composés qui inhibent les tyrosine-kinases, à des compositions qui contiennent des composés inhibiteurs de tyrosine-kinases et à des procédés d'utilisation d'inhibiteurs de tyrosine-kinases pour traiter, chez les mammifères, les affections/maladies dépendant des tyrosine-kinases telles que l'angiogenèse, le cancer, l'athérosclérose, la rétinopathie diabétique ou les maladies auto-immunes.
Bilodeau Mark T.
Cunningham April M.
Hungate Randall W.
Koester Timothy J.
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Novel angiogenesis inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel angiogenesis inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel angiogenesis inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1776002